Determinants of Change in Glycemic Status in Individuals with Prediabetes: Results from a Nationwide Cohort Study in Germany by Paprott, Rebecca et al.
Research Article
Determinants of Change in Glycemic Status in Individuals with
Prediabetes: Results from a Nationwide Cohort Study in Germany
Rebecca Paprott , Christa Scheidt-Nave, and Christin Heidemann
Department of Epidemiology and Health Monitoring, Robert Koch Institute, 12101 Berlin, Germany
Correspondence should be addressed to Christin Heidemann; heidemannc@rki.de
Received 18 April 2018; Revised 2 July 2018; Accepted 29 August 2018; Published 14 October 2018
Academic Editor: Paolo Fiorina
Copyright © 2018 Rebecca Paprott et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Previous studies investigating determinants of changes in glycemic status among individuals with prediabetes mainly focused on
glucose-defined prediabetes. In this study, we examined determinants of a regression to normoglycemia or a progression to
diabetes among individuals with HbA1c-defined prediabetes. The study included 817 participants (18–79 years) with
prediabetes (HbA1c 5.7–6.4% (39–47mmol/mol)) at baseline. Glycemic status at follow-up was categorized as diagnosed
diabetes (self-reported physician diagnosis or antidiabetic medication), undiagnosed diabetes (HbA1c≥ 6.5% (≥48mmol/mol)),
prediabetes (as defined at baseline), and normoglycemia (HbA1c< 5.7% (<39mmol/mol)). Determinants of glycemic changes
were identified by multinomial logistic regression (OR (95% CI)), with those remaining in the prediabetic state as reference.
During a mean follow-up time of 12.0 years, 33.8% of the participants reverted to normoglycemia, 7.2% progressed to
undiagnosed diabetes, 12.8% progressed to diagnosed diabetes, and 46.2% remained prediabetic. Determinants of a regression to
normoglycemia were female sex (male vs. female: 0.67 (0.46; 0.98)) and higher HDL cholesterol levels (1.17 (1.02; 1.35) per
10mg/dl). Determinants of a progression to undiagnosed or diagnosed diabetes were higher values of BMI (1.10 (1.02; 1.18);
1.13 (1.06; 1.21) per kg/m2), waist circumference (1.04 (1.01; 1.07); 1.06 (1.03; 1.09) per cm), alanine aminotransferase (1.06
(1.03; 1.09); 1.07 (1.03; 1.10) per U/l), and gamma-glutamyl transferase (1.02 (1.00; 1.03); 1.03 (1.01; 1.04) per U/l). Higher age
(1.04 (1.02; 1.06) per year), female sex (male vs. female: 0.56 (0.33; 0.97)), and parental history of diabetes (yes vs. no: 1.82
(1.05; 3.15)) were further associated with a progression to diagnosed diabetes, whereas higher triglyceride levels (1.03 (1.01;
1.06) per 10mg/dl) were associated with a progression to undiagnosed diabetes. In conclusion, among the investigated
determinants, potentially modifiable anthropometric and metabolic markers were associated with glycemic changes in individuals
with HbA1c-defined prediabetes. The findings of this study demonstrate the need for more refined case finding strategies for
diabetes prevention.
1. Introduction
Type 2 diabetes is a chronic metabolic disease character-
ized by elevated blood glucose levels that increase the risk
for severe micro- and macrovascular complications [1].
Prediabetes is considered a prestage of manifest diabetes
and is associated with an increased risk of developing type
2 diabetes [2–5]. Approximately 5% to 10% of individuals
with prediabetes progress to diabetes yearly [2]. However,
progression can be prevented by lifestyle and pharmaco-
logical interventions and prediabetes may even revert to
normoglycemia [2, 3].
Prediabetes can be defined by impaired fasting glucose
(IFG) (5.6–6.9mmol/l), impaired glucose tolerance (IGT)
(7.8–11.0mmol/l), or elevated HbA1c levels (5.7–6.4% (39–
47mmol/mol)) [5]. Previous studies on determinants of pro-
gression or regression from prediabetes were mostly based on
prediabetes defined by IFG or IGT, whereas studies using ele-
vated HbA1c levels for definition are sparse.
In these studies, among individuals with IFG or IGT,
measures of lipid metabolism [6–10] and anthropometry
[4, 8, 11–14] were associated with changes in glycemic sta-
tus. Moreover, several previous studies among persons
with IFG or IGT examined the effect of modifiable lifestyle
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factors (mostly physical activity, smoking, and alcohol
intake) on glycemic changes but the majority did not find
an association [4, 6–10, 15–17]. In addition, a recent study
that included individuals with HbA1c-defined prediabetes
found no association between physical activity and a
regression to normoglycemia [17].
Since the characteristics of individuals with prediabetes
who are diagnosed by different criteria may vary due to
differences in the underlying pathophysiological pathways
[2, 18], determinants of changes in glycemic status may
also differ according to the applied diagnostic criterion.
In the present study, we therefore aimed to identify deter-
minants of a regression to normoglycemia or a progression to
undiagnosed or diagnosed diabetes in a nationwide sample of
German adults with HbA1c-defined prediabetes who were
followed for 12 years. In addition to sociodemographic char-
acteristics, we investigated potentially modifiable risk factors
such as anthropometric, metabolic, and lifestyle factors as
determinants of change in glycemic status.
2. Materials and Methods
2.1. National Health Examination Surveys. The “German
National Health Interview and Examination Survey 1998”
(GNHIES98) was conducted from 1997 to 1999 and targeted
the residential German population aged 18 to 79 years
(response: 61%). A two-stage cluster sampling procedure
was applied. First, sample points were selected, and then,
age- and sex-stratified random samples from local popula-
tion registries were drawn [19]. Out of all GNHIES98 partic-
ipants, 3959 participants (response: 62%) also took part in
the subsequent “German Health Interview and Examination
Survey for Adults” (DEGS1), conducted from 2008 to 2011
(Figure 1) [20]. Both surveys were conducted in accordance
with the Declaration of Helsinki and approved by the Federal
and State Commissioners for Data Protection. DEGS1 was
approved by the ethics committee of the Charité-
Universitätsmedizin Berlin (No. EA2/047/08). Participants
provided written informed consent before participation [20].
2.2. Study Population. Figure 1 depicts a flow chart reflecting
the composition of the study population. After applying
different exclusion criteria among those who participated
in both GNHIES98 (baseline) and DEGS1 (follow-up), a
cohort consisting of 2900 participants remained. The final
study sample comprised 817 participants with prediabetes
at baseline.
2.3. Assessment of Glycemic Status. Diagnosed diabetes was
determined by a self-reported history of diagnosed diabetes
assessed in physician-administered standardized interviews
or by the intake of antidiabetic agents within the 7 days prior
to the interview documented through a detailed medication
review. Among participants without diagnosed diabetes, nor-
moglycemia (HbA1c< 5.7% (<39mmol/mol)), prediabetes
(HbA1c 5.7–6.4% (39–47mmol/mol)), and undiagnosed dia-
betes (HbA1c≥ 6.5% (≥48mmol/mol)) were defined accord-
ing to recent ADA recommendations [5]. In GNHIES98,
HbA1c was measured using a Diamat high-performance
liquid chromatography (HPLC) analyzer (Bio-Rad Laborato-
ries, Munich, Germany) and RECIPE reagents (RECIPE
Chemicals and Instruments, Munich, Germany). In DEGS1,
HbA1cwasmeasured using an immunoturbidimetricmethod
(ARCHITECT ci8200; Abbott, Wiesbaden, Germany). Both
methods were traceable to the National Glycohemoglobin
Standardization Program [21], and no systematic devia-
tion of HbA1c measurements between the surveys was
evident [22].
2.4. Assessment of Risk Factors for Type 2 Diabetes. The
assessment of several health-related risk factors inGNHIES98
has been previously described in detail [20, 22–25]. Briefly,
information about educational level, sport activity, smok-
ing status, residential traffic intensity, and mental distress
was obtained through a standardized self-administered
questionnaire. For the current analyses, middle and high
educational levels were combined. Sport activity was ascer-
tained as regular sport activity over the past three months
and categorized as either no sport or any sport. Smoking
status was categorized into never, former, and current
smoker. Residential traffic intensity was dichotomized into
rare to considerable traffic versus heavy to extreme traffic.
Psychosocial distress was measured by the Mental Health
Inventory (MHI-5) on a scale ranging from 0 to 100
points, with lower values indicating mental distress and
higher values indicating mental well-being. A parental his-
tory of diabetes was assessed in DEGS1 through a stan-
dardized physician-administered personal interview. In
GNHIES98, measures of body height, weight, and waist
circumference were obtained while participants wore light
clothing. BMI was calculated as the ratio of body weight
(kg) and height squared (m2).
The intake of coffee, red meat, and whole grains (includ-
ing whole grain bread, buns, and muesli) (as components of
the German Diabetes Risk Score (GDRS) that is described
below) was assessed through a questionnaire on frequency
of consumption of these food groups. The average amount
consumed per day was estimated by further considering
information on dietary intake assessed through a diet history
method in a GNHIES98 subsample (n = 4030) as previously
described [23].
As a summary measure of overall risk for type 2 diabetes,
we calculated the GDRS including age, height, waist circum-
ference, history of hypertension, physical activity, smoking,
family history of diabetes, and intake of coffee, red meat,
and whole grains as score components [26]. The GDRS has
been shown to be a valid tool for prediction of diagnosed dia-
betes in the general adult population [23].
Venous blood samples were taken, processed within an
hour, and stored at −40°C in the central laboratory unit at
the Robert Koch Institute until further analyses. HDL choles-
terol was determined based on the cholesterol oxidase-
peroxidase 4-aminophenazone method (MEGA, Merck,
Darmstadt, Germany) (intra-assay CV: 1.2–2.5%). Triglycer-
ides were determined by the glycerol-3-phosphate oxidase-
peroxidase 4-aminophenazone method using the MEGA
measurement device (Merck, Darmstadt, Germany) (intra-
assay CV: 1.6–2.2%). Both gamma-glutamyl transferase
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(GGT) and alanine aminotransferase (ALT) were measured
according to standards of the DGKC (German Association
of Clinical Chemistry) (EPOS, Eppendorf, Wesseling, Ger-
many) (intra-assay CV for GGT: 1.3–2.7%; for ALT: 1.1–
4.8%). High-sensitivity C-reactive protein (hs-CRP) was
measured in serum by an immunoturbidimetric method
(ARCHITECT ci8200, Abbott, Munich, Germany) (intra-
assay CV: 4.0).
Additionally, diagnosed hypertension, hyperlipidemia,
myocardial infarction, and stroke were considered as comor-
bidities and assessed through a physician-administered per-
sonal interview. The use of statins and thiazide diuretics
was considered as concomitant therapy known to favor the
progression from prediabetes to diabetes and was ascertained
through a detailed medication review. However, we found
that the number of participants taking thiazide diuretics
(n = 20) or statins (n = 32) at the time of baseline examina-
tion (1997–99) was too low to enable further analyses.
2.5. Statistical Analysis. The SAS software 9.4 (SAS Institute
Inc., Cary, NC) was used for all statistical analyses. A
weighting factor was applied that corrects for deviations of
the DEGS1 sample from population figures from the Federal
Statistical Office (as of 31 December 2010) and accounts for
the incomplete follow-up [27]. For the current analyses, the
probability of GNHIES98 participants with prediabetes par-
ticipating in DEGS1 was derived from a generalized linear
mixed model with age at the time of GNHIES98 (4 catego-
ries) and age at the time of DEGS1 (8 categories), as well as
smoking (yes or no), education (3 categories), income (3 cat-
egories), and migration background (yes or no) at the time of
GNHIES98, as independent variables.
Multinomial logistic regression was performed to calcu-
late the odds ratios (OR) and 95% confidence intervals (CI)
for considered risk factors. For the dependent variable, three
categories were defined according to a participant’s glycemic
status at follow-up, with those who remained in the predia-
betic state as the reference group. In the case of a regression
to normoglycemia, an OR> 1.00 indicates a higher chance
for a regression (i.e., favorable). In the case of a progression
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Figure 1: Flow chart showing the definition and distribution of participants within categories of glycemic status. Definitions applied for
glycemic status were the same at baseline and follow-up. The numbers shown were drawn from the unimputed data set.
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We classified a total of 19 potential determinants
(Table 1) into the following categories and subcategories:
(1) unmodifiable diabetes risk factors comprising sociode-
mographic factors and family history of diabetes and (2)
potentially modifiable risk factors, including anthropometric
markers, lifestyle factors, residential traffic intensity, mental
distress, the diabetes risk score (as a summary measure of
predominantly modifiable factors), and metabolic markers.
Risk factors were examined in separate multinomial
regression models, adjusting for age and sex (model 1). For
potentially modifiable risk factors, a second model (model
2) was fitted that additionally adjusted for educational level
and other potential confounders that were selected by apply-
ing directed acyclic graphs [28].
Among individuals with prediabetes at baseline, 22% had
missing data in at least one of the considered determinants.
To account for the missing values, multiple imputation was
applied that included all potential determinants, glycemic











n (%) 300 (33.8%) 364 (46.2%) 52 (7.2%) 101 (12.8%)
Unmodifiable risk factors
Sociodemographic factors
Age (years) 48.5 (45.9; 51.1) 49.6 (47.6; 51.7) 53.8 (50.5; 57.2) 57.0 (54.8; 59.2)
Male sex 53.3 (46.5; 60.1) 61.5 (54.8; 67.8) 48.1 (30.4; 66.2) 41.6 (31.1; 52.9)
Educational level
Low 52.2 (45.0; 59.4) 52.6 (45.6; 59.6) 52.4 (34.2; 70.2) 71.8 (61.6; 82.0)
Medium/high 47.8 (40.6; 55.0) 47.4 (40.4; 54.4) 47.3 (29.8; 65.8) 28.2 (18.0; 38.4)
Family history of diabetes
At least one parent with diabetes 27.1 (19.6; 34.5) 35.4 (29.9; 40.8) 31.1 (10.6; 51.6) 46.7 (34.6; 58.8)
Modifiable risk factors
Anthropometric markers
BMI (kg/m2) 26.6 (25.8; 27.3) 27.5 (27.0; 28.1) 29.6 (28.5; 30.6) 30.4 (29.3; 31.6)
Waist circumference (cm) 91.1 (89.1; 93.1) 94.3 (92.8; 95.7) 98.6 (94.7; 102.5) 101.3 (98.0; 104.5)
Lifestyle factors
Any sport activity per week 44.9 (37.5; 52.4) 51.2 (44.3; 58.1) 43.8 (29.1; 59.9) 39.6 (29.8; 49.4)
Smoker at baseline
Never 36.9 (30.4; 43.4) 38.2 (31.4; 45.0) 51.2 (36.5; 65.9) 43.9 (33.1; 54.7)
Former 16.7 (11.7; 21.7) 24.7 (19.7; 29.7) 26.7 (15.6; 42.1) 25.2 (15.7; 34.8)
Current 46.4 (39.1; 53.8) 37.1 (30.9; 43.3) 21.8 (11.9; 36.7) 30.9 (20.7; 41.1)
Intake of whole grains (portions/day) 1.3 (1.2; 1.5) 1.2 (1.1; 1.4) 1.0 (0.8; 1.2) 1.1 (1.0–1.3)
Intake of red meat (portions/day) 0.58 (0.55; 0.60) 0.59 (0.57; 0.61) 0.54 (0.50; 0.58) 0.52 (0.47–0.57)




25.5 (18.3; 32.7) 23.5 (17.7; 29.4) 28.1 (13.5; 49.6) 33.5 (22.8; 44.2)
Mental distress (points) 73.9 (71.6; 76.1) 75.4 (73.3; 77.4) 79.0 (74.2; 83.7) 70.9 (67.0; 74.8)
GDRS (points) 538 (514; 563) 575 (557; 592) 633 (599; 666) 690 (661; 720)
Metabolic markers
HDL cholesterol (mg/dl) 56.4 (53.5; 59.4) 52.4 (50.4; 54.6) 51.3 (47.9; 54.9) 50.3 (47.5; 53.2)
Triglycerides (mg/dl) 121.9 (111.0; 133.8) 144.1 (134.2; 154.7) 187.0 (150.2; 232.9)
175.2 (155.0;
198.0)
GGT (U/l) 13.9 (12.7; 15.1) 15.6 (14.6; 16.7) 18.9 (16.2; 22.1) 20.1 (17.2; 23.5)
ALT (U/l) 12.3 (11.4; 13.2) 12.7 (12.0; 13.5) 16.0 (13.3; 19.2) 15.0 (13.5; 16.5)
hs-CRP (mg/l) 1.4 (1.1; 1.7) 1.3 (1.2; 1.5) 1.4 (0.9; 2.3) 2.3 (1.7; 3.1)
Information is given as weighted proportions (95% CI) for categorical variables, as weighted arithmetic mean (95% CI) for continuous variables, and in case of
metabolic markers and predicted 5-year diabetes risk as weighted geometric mean (95% CI). Differences in proportions and means between groups of glycemic
status (reference group: remained prediabetic) were assessed by logistic regression and ANOVA. Bold numbers indicate p < 0 05.
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status at follow-up, the weighting factor, and the cluster
variable. The SAS procedure “PROC MI” with the fully con-
ditional specification method for an arbitrary pattern of
missingness was used, and 25 complete data sets were
imputed [29, 30]. The fraction of missing information ranged
from <0.001 for height to 0.08 for hs-CRP. The relative effi-
ciency was >0.99 for all risk factors imputed. SAS survey pro-
cedures were also applied to the individual imputed data sets
again using the weighting factor and the cluster variable [29].
Results from the individual imputed data sets were then com-
bined using the SAS procedure “PROC MIANALYZE,”
which accounts for the variability between the results of
imputed data sets [31].
A considerable proportion of participants had an HbA1c
level of 5.7% (39mmol/mol; equivalent to 26.1%) or of 6.4%
(47mmol/mol; equivalent to 2.4%), i.e., an HbA1c level that
was borderline for the definition of normoglycemia or diabe-
tes, respectively. Therefore, relevant changes in glycemic sta-
tus were defined for a sensitivity analysis as a change in the
category of glycemic status combined with a change of at
least ±0.3 percentage points in HbA1c. This definition of a
relevant glycemic change was adapted from Kowall et al.,
who defined relevant changes in glycemic status based on
fasting or 2 h glucose [12].
In additional analyses, the associations between
changes in modifiable risk factors during follow-up and
changes in glycemic status were examined. A change in a
modifiable risk factor was defined as the measurement at
follow-up minus the measurement at baseline. In addition
to models 1 and 2 described above, a third model (model
3) was analyzed additionally including the baseline value
of the respective risk factor.
3. Results
During a mean follow-up time of 12.0 years, 7.2% of the
817 participants with prediabetes at baseline progressed to
undiagnosed diabetes and 12.8% progressed to diagnosed
diabetes. During the same period, 33.8% reverted to
normoglycemia and 46.2% remained prediabetic (Table 1).
When considering relevant changes in glycemic status, the
proportion of participants who reverted to normoglycemia
was 28.1% (95% CI: 22.5–34.4%), while 51.9% (46.2–
57.6%) remained in the prediabetic stage. The proportion
of participants with a progression to undiagnosed or diag-
nosed diabetes remained unchanged (data not shown).
Baseline characteristics of participants according to
changes in glycemic status during follow-up are shown in
Table 1. Compared to those who remained in the prediabetic
state, participants who regressed to normoglycemia had
lower values for BMI, waist circumference, triglycerides,
GGT, and the diabetes risk score. Additionally, they showed
higher levels of HDL cholesterol. On the other hand, partic-
ipants who progressed to diagnosed or undiagnosed diabetes
were older and had higher values for BMI, waist circumfer-
ence, triglycerides, GGT, ALT, and the diabetes risk score.
Those who progressed to diagnosed diabetes were also more
often female, living in streets with heavy or extreme residen-
tial traffic intensity, of a low educational level, and
characterized by a lower intake of red meat and a higher level
of hs-CRP. Those who progressed to undiagnosed diabetes
were less likely to be current smokers and had a lower intake
of whole grains compared to those who remained prediabetic.
Additional descriptive analyses considering diagnosed
comorbidities at baseline (hypertension, hyperlipidemia,
myocardial infarction, and stroke) showed that, as expected,
participants with a progression to diagnosed diabetes were
more likely and those with a regression to normoglycemia
were less likely to have been diagnosed with hypertension
or hyperlipidemia than those who remained prediabetic. No
significant differences across categories of glycemic changes
were observed with respect to myocardial infarction and
stroke (data not shown).
Table 2 depicts the association between the investigated
baseline determinants and changes in glycemic status as
determined from multivariate analyses. Among the unmodi-
fiable risk factors, female sex was associated with a regression
to normoglycemia and a progression to diagnosed diabetes.
Higher age and a parental history of diabetes were associated
with a progression to diagnosed diabetes. Among the poten-
tially modifiable risk factors, higher levels of HDL cholesterol
and lower values of the diabetes risk score were associated
with a regression to normoglycemia. Higher values of BMI,
waist circumference, GGT, ALT, and the diabetes risk score
were associated with a progression to both undiagnosed dia-
betes and diagnosed diabetes. In addition, a higher triglycer-
ide level was associated with a progression to undiagnosed
diabetes. The lifestyle factors considered, residential traffic
intensity, and mental distress were not individually associ-
ated with a change in glycemic status. The results persisted
when analyses were repeated considering only relevant glyce-
mic changes (data not shown).
Further analyses of changes in potentially modifiable risk
factors between baseline and follow-up (Supplementary
Table 1) revealed that decreases in the levels of BMI (OR:
0.86 (95% CI: 0.77–0.95)), waist circumference (0.96 (0.93–
0.99)), and triglycerides (0.94 (0.89–1.00)) during follow-up
were associated with a regression to normoglycemia. How-
ever, an increased waist circumference (1.04 (1.00–1.08))
was associated with a progression to undiagnosed diabetes
whereas an increased triglyceride level (1.05 (1.02–1.09))
was related to a progression to diagnosed diabetes. An
increase in the diabetes risk score during follow-up was asso-
ciated with a progression to undiagnosed diabetes (1.04
(1.01–1.08)) and to diagnosed diabetes (1.06 (1.01–1.10)).
4. Discussion
After 12.0 years of follow-up, 20% of HbA1c-defined predia-
betic adults from a nationwide German study had progressed
to diagnosed or undiagnosed diabetes, whereas 46% had
remained prediabetic and 34% had reverted to normoglyce-
mia. Figure 2 provides an overview of the hypothesized
determinants of the study and its findings. Among the unmo-
difiable risk factors, female sex was related to a higher chance
of a regression to normoglycemia and a progression to diag-
nosed diabetes. Additionally, older age and a parental diabe-
tes history were related to a higher chance of a progression to
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diagnosed diabetes. Among potentially modifiable risk fac-
tors considered in the current study at baseline, favorable
HDL cholesterol levels were related to a regression to normo-
glycemia. Less favorable levels of anthropometric markers
and liver enzymes were associated with a progression to
undiagnosed diabetes and diagnosed diabetes. In addition,
less favorable triglyceride levels were related to a progression
to undiagnosed diabetes. Higher values of the diabetes risk
score as a summary measure of predominantly modifiable
risk factors were associated with a progression to undiag-
nosed diabetes and diagnosed diabetes, whereas lower values
were related to a regression to normoglycemia.
4.1. Discussion of Main Results. In this cohort, women had a
higher chance of both a regression to normoglycemia and a
progression to diagnosed diabetes. This finding might reflect
a higher utilization of healthcare and greater health con-
sciousness among women compared to men [32]. Higher
age was associated with progression to diagnosed diabetes,
confirming the well-known positive association between
aging and the risk of type 2 diabetes. In addition, our findings
related to a parental history of diabetes are consistent with
findings from previous studies, indicating that individuals
with a family history of diabetes are more likely to have
their glucose level tested [33] and that a family history
of diabetes probably affects an individual’s knowledge of
having diabetes [34].
Our findings regarding BMI and waist circumference
mostly comport with findings from previous studies examin-
ing progression from IFG or IGT to diabetes [8, 11, 13, 14]. In
contrast with our findings, previous studies from India and
South Africa did not detect an association between waist cir-
cumference and a progression to diabetes [6, 35]. This dis-
parity in results might be partly explained by the different
ethnic groups included in the study populations. In our
study, only decreases in BMI and waist circumference during
follow-up but not their baseline values determined regression
to normoglycemia. This finding is consistent with results of
regional cohort studies of individuals with IFG or IGT in
Germany [12] or the UK [4].
Interestingly, in multivariate analyses, none of the con-
sidered lifestyle factors was significantly associated with gly-
cemic changes. This was also the case for fruit or vegetable
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Figure 2: Overview on hypothesized determinants and study results. ↑ is equivalent to “higher at baseline/increase during follow-up”; ↓ is
equivalent to “lower at baseline/decrease during follow-up”; BMI: body mass index; WC: waist circumference; HDL: high-density
lipoprotein; GGT: gamma-glutamyl transferase; ALT: alanine aminotransferase; hs-CRP: high-sensitivity C-reactive protein.
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alcohol (data not shown). For physical activity, our null
finding is consistent with the majority of previous studies
that define glycemic status based on IFG, IGT [4, 6, 7, 9,
10, 15, 17], or HbA1c [17]. Only a few prior studies have
investigated the association between dietary behaviors and
changes in glycemic status in individuals with prediabetes,
and the results have been inconsistent [7, 16]. The same is
true for the association between smoking status and
changes in glycemic status in individuals with prediabetes
[6–10]. Differences in results might be explained by differ-
ences in the accuracy of the assessment methods used. In
most epidemiological studies, including the present study,
lifestyle factors are assessed through self-reporting, which
is considered a rather imprecise method and is moreover
prone to social desirability and recall bias [36, 37]. Given
the high potential for misclassification, existing associa-
tions between lifestyle factors and change in glycemic sta-
tus might not be detected [4]. In the case of physical
activity, we also had to combine the assessed 5 categories
into a dichotomous variable due to the relatively small
sample sizes in certain categories, which might have been
too broad to identify existing associations. Of particular
relevance to dietary intake, a further explanation for our
null finding might be that the influence of individual die-
tary components is fairly small and therefore difficult to
detect. In the present study, values of the diabetes risk score
had the expected associations with glycemic changes. These
findings could not be fully explained by waist circumference
or age (as two main score components) and thus highlight
the value of a multifactorial diabetes risk assessment. In addi-
tion, a recent interventional study suggests that among indi-
viduals with prediabetes, there might be a high-risk
phenotype that does not respond to lifestyle interventions
such as dietary counseling and exercise [38–40].
Despite their discussed role in diabetes pathophysiology,
traffic intensity and mental distress were also not related to
glycemic changes among prediabetic adults in multivariate
analyses. While we did not find a comparable study on
traffic-related exposures, one study showed that mental loss
as assessed by the mental component score of the SF-12 ques-
tionnaire was associated with a progression to diabetes in
adults with IFG or IGT [41].
Similar to our findings, previous studies of individuals
with IFG found higher baseline levels [7, 8, 10] or an increase
in triglycerides [7] to be associated with a progression in
glycemic status. However, the results that show a progression
in glycemic status are less consistent for studies that analyze
individuals with IFG and IGT together [6, 9, 35]. Only a
few previous studies have explored measures of lipid metab-
olism with respect to a regression in glycemic status from IFG
or IGT, and the findings have been inconsistent [9, 10]. The
findings of the current study for liver enzymes, i.e., the asso-
ciation of higher GGT and ALT levels with progression in
glycemic status, are in line with findings for GGT observed
for individuals with IFG or IGT in a South African cohort
[35]. With respect to hs-CRP, a study among Chinese adults
with IGT found that higher levels of hs-CRP indicated a
progression to diabetes [42], whereas no association with
glycemic changes was observed in our study.
4.2. Limitations. This nationwide cohort study comprised
participants from the general adult population in Germany
covering a wide age range. However, the follow-up rate was
rather moderate and the GNHIES98 participants who took
part in the follow-up survey had some different characteris-
tics from those who did not reparticipate or were deceased
[24]. To account for differences arising from nonparticipa-
tion, a weighting factor was computed following the
approach described above [27] and applied to all analyses
in the present study.
Despite the application of a weighting factor, our study
population might have been healthier compared to other
studies. This was reflected by a higher proportion (34%)
of individuals who reverted to normoglycemia compared
to some other studies. For example, the proportion of par-
ticipants with a regression was 4.4% based on data from
the Whitehall II study, which applied the same definition
for prediabetes but had a shorter follow-up time [17].
On the other hand, similar to that in our study, the pro-
portion of individuals with a progression to diabetes was
approximately one-fifth of participants in the Atheroscle-
rosis Risk in Communities (ARIC) study, which used the
same prediabetes definition and a similar follow-up length
[43] as those of our study. One reason for the rather high pro-
portion of individuals who reverted to normoglycemia in our
study might be the relatively high proportion of individuals
at the lower threshold of HbA1c-defined prediabetes. Thus,
in a sensitivity analysis, we applied a stricter definition to
identify only relevant changes in glycemic status. Nonethe-
less, the results remained largely unchanged.
Moreover, the proportion of participants with a migra-
tion background was rather low, and therefore, ethnicity
could not be taken into account as a potential determining
factor for glycemic changes [44]. We also had no information
on whether participants only temporarily progressed to dia-
betes or regressed to normoglycemia between baseline and
follow-up [45]. Further, we cannot rule out that the observed
associations between changes in risk factors and changes in
glycemic status in the additional analyses might be biased
from reverse causation. Moreover, we did not adjust for mul-
tiple testing since analyses were exploratory.
Based on HbA1c measures and information about diabe-
tes diagnosis, the present study permitted the identification
of similarities and differences in the progression to diagnosed
and undiagnosed diabetes. However, due to the lack of addi-
tional markers of glucose metabolism, we were unable to
directly compare findings between individuals whose predia-
betes was based on HbA1c and those whose prediabetes was
defined by glucose criteria (e.g., IFG or IGT). The definition
of prediabetes based on either of these measures might be
too narrow, and a more refined identification of subgroups
at high risk of developing diabetes remains a challenge with
high relevance for the development of effective case finding
and prevention strategies [38, 39, 46].
5. Conclusion
In this nationwide cohort of German adults who were
followed for 12 years, approximately one-third of the
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individuals with HbA1c-based prediabetes reverted to nor-
moglycemia and one-fifth progressed to self-reported diag-
nosed or HbA1c-based undiagnosed diabetes. Measures of
anthropometry and lipid metabolism at baseline or as change
during follow-up showed the most consistent associations
with changes in glycemic status in both directions. In addi-
tion, elevated liver enzymes were related to the future devel-
opment of undiagnosed or diagnosed diabetes; older age and
a family history of diabetes were further associated with
future diagnosed diabetes. In contrast with results from pre-
vious studies that primarily relied on glucose-based defini-
tions of prediabetic states, the findings of the current study
appear to be more variable for metabolic than for anthropo-
metric markers. This difference is not surprising, given that
the use of different diagnostic criteria to define glycemic sta-
tus is likely to represent different pathophysiological states of
glucose dysregulation. Our results further support the rele-
vance of the HbA1c criterion in the definition of prediabetes
and also demonstrate the need for more refined case finding
strategies for diabetes prevention.
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